THE REPLACE REGISTRY Trademark

Trademark Overview

On Monday, March 29, 2021, a trademark application was filed for THE REPLACE REGISTRY with the United States Patent and Trademark Office. The USPTO has given the THE REPLACE REGISTRY trademark a serial number of 90610195. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 20, 2025. This trademark is owned by Travere Therapeutics, Inc.. The THE REPLACE REGISTRY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

registry services, namely, conducting a registry study in the field of pharmaceuticals and providing educational information in the nature of study results in the field of pharmaceuticals for the purpose of educating healthcare practitioners
the replace registry

General Information

Serial Number90610195
Word MarkTHE REPLACE REGISTRY
Filing DateMonday, March 29, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, February 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2023

Trademark Statements

NOT AVAILABLE"REGISTRY"
Goods and Servicesregistry services, namely, conducting a registry study in the field of pharmaceuticals and providing educational information in the nature of study results in the field of pharmaceuticals for the purpose of educating healthcare practitioners

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMIRUM PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressFOSTER CITY, CA 94404
Party NameTravere Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameTravere Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Friday, October 29, 2021ASSIGNED TO EXAMINER
Thursday, April 1, 2021NEW APPLICATION ENTERED
Monday, July 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 5, 2021NON-FINAL ACTION WRITTEN
Thursday, May 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 5, 2021NON-FINAL ACTION E-MAILED
Friday, November 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 7, 2022NON-FINAL ACTION WRITTEN
Thursday, July 7, 2022NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 27, 2023ASSIGNED TO LIE
Monday, March 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 27, 2023FINAL REFUSAL WRITTEN
Thursday, April 27, 2023FINAL REFUSAL E-MAILED
Thursday, April 27, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 26, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 12, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2024USE AMENDMENT FILED
Tuesday, April 23, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, May 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, August 2, 2024SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 30, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, November 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, December 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 2, 2024NON-FINAL ACTION E-MAILED
Friday, August 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, February 20, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, December 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 18, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

registry replace pharmaceuticals field study purpose results practitioners healthcare educating nature